Literature DB >> 19429517

Single and repeated bleomycin intratracheal instillations lead to different biomechanical changes in lung tissue.

M Pinart1, A Serrano-Mollar, R Llatjós, P R M Rocco, P V Romero.   

Abstract

Single dose of bleomycin induces acute alveolitis followed by a reparative process whilst a repeated dose results in progressive fibrosis, which may lead to distinct lung tissue biomechanical changes. To test this hypothesis, rats were intratracheally instilled with saline (N=11) or bleomycin (2.5U/kg) once (SD, N=8) or three times (RD, N=9) one week apart, and sacrificed 28 days after challenge. Forced oscillatory mechanics as well as the amount of collagen fibre and myeloperoxidase content (MPO(L)) were studied in lung tissue strips. Both elastic modulus (H), tissue damping (G), and MPO(L) increased only in RD-challenged rats. Although fibroblast focus was found in RD, collagen fibre content increased in both challenged groups. However, the amount of collagen fibre in SD group was not enough to induce lung tissue mechanical changes. In conclusion, repeated doses of bleomycin induce inflammatory and fibrogenic behaviour with biomechanical changes mimicking interstitial lung disease in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429517     DOI: 10.1016/j.resp.2009.01.002

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  8 in total

1.  Quantitative assessment of lung ventilation and microstructure in an animal model of idiopathic pulmonary fibrosis using hyperpolarized gas MRI.

Authors:  Michael J Stephen; Kiarash Emami; John M Woodburn; Elaine Chia; Stephen Kadlecek; Jianliang Zhu; Stephen Pickup; Masaru Ishii; Rahim R Rizi; Milton Rossman
Journal:  Acad Radiol       Date:  2010-11       Impact factor: 3.173

2.  Fish Oil Nanoemulsion Supplementation Attenuates Bleomycin-Induced Pulmonary Fibrosis BALB/c Mice.

Authors:  Danielle Galdino de Souza; Débora Silva Santos; Karina Smidt Simon; José Athayde Vasconcelos Morais; Luísa Coutinho Coelho; Thyago José Arruda Pacheco; Ricardo Bentes Azevedo; Anamélia Lorenzetti Bocca; César Augusto Melo-Silva; João Paulo Figueiró Longo
Journal:  Nanomaterials (Basel)       Date:  2022-05-14       Impact factor: 5.719

3.  Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion.

Authors:  Rudolf K Braun; Jill M Koch; Timothy A Hacker; David Pegelow; Jaehyup Kim; Amish N Raval; Eric G Schmuck; Denise J Schwahn; Derek J Hei; John M Centanni; Marlowe Eldridge; Peiman Hematti
Journal:  Cytotherapy       Date:  2016-04       Impact factor: 5.414

4.  STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.

Authors:  Mesias Pedroza; Thuy T Le; Katherine Lewis; Harry Karmouty-Quintana; Sarah To; Anuh T George; Michael R Blackburn; David J Tweardy; Sandeep K Agarwal
Journal:  FASEB J       Date:  2015-08-31       Impact factor: 5.191

Review 5.  Lung parenchymal mechanics.

Authors:  Béla Suki; Dimitrije Stamenović; Rolf Hubmayr
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 6.  Mechanobiology in lung epithelial cells: measurements, perturbations, and responses.

Authors:  Christopher M Waters; Esra Roan; Daniel Navajas
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

7.  Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-β1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt.

Authors:  Alícia Giménez; Paula Duch; Marta Puig; Marta Gabasa; Antoni Xaubet; Jordi Alcaraz
Journal:  Int J Mol Sci       Date:  2017-11-16       Impact factor: 5.923

8.  Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study.

Authors:  Yuben Moodley; Vijesh Vaghjiani; James Chan; Svetlana Baltic; Marisa Ryan; Jorge Tchongue; Chrishan S Samuel; Padma Murthi; Ornella Parolini; Ursula Manuelpillai
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.